Citadel Advisors’s Crescent Capital BDC CCAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$149K Buy
+12,300
New +$168K ﹤0.01% 11686
2025
Q2
Sell
-5,400
Closed -$92.4K 12721
2025
Q1
$92.4K Sell
5,400
-3,000
-36% -$55.8K ﹤0.01% 11587
2024
Q4
$161K Sell
8,400
-18,000
-68% -$340K ﹤0.01% 10776
2024
Q3
$488K Buy
26,400
+7,700
+41% +$143K ﹤0.01% 8306
2024
Q2
$351K Sell
18,700
-36,700
-66% -$655K ﹤0.01% 8823
2024
Q1
$956K Buy
55,400
+25,100
+83% +$422K ﹤0.01% 7005
2023
Q4
$527K Buy
30,300
+700
+2% +$11.6K ﹤0.01% 7980
2023
Q3
$506K Sell
29,600
-6,900
-19% -$114K ﹤0.01% 8051
2023
Q2
$553K Buy
36,500
+5,800
+19% +$81.3K ﹤0.01% 7727
2023
Q1
$418K Buy
30,700
+21,200
+223% +$307K ﹤0.01% 8671
2022
Q4
$121K Sell
9,500
-21,500
-69% -$292K ﹤0.01% 10941
2022
Q3
$466K Buy
31,000
+7,200
+30% +$121K ﹤0.01% 8621
2022
Q2
$369K Buy
23,800
+4,100
+21% +$70.3K ﹤0.01% 9323
2022
Q1
$351K Buy
+19,700
New +$352K ﹤0.01% 10222

Other funds holding CCAP

Citadel Advisors's CCAP Position: Q1 2026 in Review

Citadel Advisors sold out of Crescent Capital BDC (CCAP) in Q1 2026, closing a stake of 34,215 shares — an estimated $468K sold.

Citadel Advisors first reported a position in CCAP in Q3 2020 and held it in 16 quarters. The position peaked at $2.53M in Q1 2023. 85 funds tracked by Wall St. Rank hold CCAP as of Q1 2026.

  • Citadel Advisors reported no remaining Crescent Capital BDC position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 34,215 Crescent Capital BDC shares in Q1 2026, an estimated $468K.
  • Citadel Advisors first reported a position in Crescent Capital BDC in Q3 2020 and held it in 16 quarters.
  • Citadel Advisors's Crescent Capital BDC position peaked at $2.53M in Q1 2023.
  • 85 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.